Verigene® Processor SP (Refurbished) 10-0000-07RRecalls & reported problems
Luminex Corporation · The Verigene® Processor SP is an instrument which integrates sample preparation, target amplification, and target hybridization within a single device as part of the Verigene® System, a benchtop molecular diagnostics workstation that utilizes patented gold nanoparticle technology to detect nucleic acid targets of interest for a variety of applications. (Refurbished) · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 3
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00840487101490), received between Jun 8, 2022 and Aug 4, 2022 — classified as 6 malfunctions.
The most frequently reported specific device problem is “Output Problem” (4 reports).
3 FDA recall records name this device's identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Recalls naming this device
- Mar 18, 2021Open, Classified
Potential for a false-negative result for Vibrio parahaemolyticus, Salmonella, and/or Shigella spp when used with the VERIGENE Enteric Pathogens Nucleic Acid Test Kit.
Z-1488-2021 · Root cause: Process control · Recall details · FDA record ↗
- Jun 15, 2020Terminated
An instrument failure mode that may result in a Blood Culture Gram Positive (BC-GP) or Gram Negative (BC-GN) false negative call.
Z-2776-2020 · Root cause: Device Design · Recall details · FDA record ↗
- Jun 15, 2020Terminated
An instrument failure mode that may result in a Blood Culture Gram Positive (BC-GP) or Gram Negative (BC-GN) false negative call.
Z-2775-2020 · Root cause: Device Design · Recall details · FDA record ↗
Most reported problems
Device problems
- Output Problem4
- Failure of Device to Self-Test2
Patient problems
- Insufficient Information4
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 4, 2022Failure of Device to Self-Test
THE SERVICE VISIT AT BLANCHARD VALLEY HEALTH SYSTEM WAS SCHEDULED AFTER THE CUSTOMER REPORTED NO CALLS USING THE BC-GP AND BC-GN ASSAY WITHIN WORK ORDER WO-00199347. DURING THE SITE VISIT, THE AMPLIFICATION (AMP) HEATER REQUIRED RECALIBRATION DUE TO FAILING INITIAL VERIFICATION AT SETPOINT 3. FIELD QUALITY UPDATED RISK ASSESSMENT QUESTIONS 7 AND 8 TO 'YES' SINCE THE SETPOINT TEMPERATURES FAILED OUTSIDE THE ACCEPTED LIMITS ESTABLISHED BY THE VERIGENE I ASSAY TEMPERATURE TOLERANCE GUARD BAND RISK REPORT (03838).
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15170120 ↗MalfunctionAug 4, 2022Output Problem
THE SERVICE VISIT AT RUTLAND REGIONAL MEDICAL CENTER WAS SCHEDULED AFTER THE CUSTOMER REPORTED REPEATED NO-CALL INTERNAL CONTROL FAILURES ON THE EP ASSAY WITHIN WORK ORDER (B)(4). DURING THE SITE VISIT, THE HYBRIDIZATION (HYB) HEATER REQUIRED RECALIBRATION DUE TO FAILING INITIAL VERIFICATION AT SETPOINT 1 AND 2. FIELD QUALITY UPDATED RISK ASSESSMENT QUESTIONS 7 AND 8 WERE UPDATED TO 'YES' SINCE THE SETPOINT TEMPERATURE FAILED OUTSIDE THE ACCEPTED LIMITS ESTABLISHED BY THE VERIGENE I ASSAY TEMPERATURE TOLERANCE GUARD BAND RISK REPORT (B)(4).
Patient problems: Insufficient Information
MAUDE report 15170099 ↗MalfunctionAug 4, 2022Failure of Device to Self-Test
THE SERVICE VISIT AT HC SYSTEMS LLC WAS SCHEDULED ACTION-21-014 WITHIN WORK ORDER (B)(4). DURING THE SITE VISIT, THE HYBRIDIZATION (HYB) HEATER REQUIRED RECALIBRATION DUE TO FAILING INITIAL VERIFICATION AT SETPOINT 2. FIELD QUALITY UPDATED RISK ASSESSMENT QUESTIONS 7 AND 8 WERE UPDATED TO 'YES' SINCE THE SETPOINT TEMPERATURE FAILED OUTSIDE THE ACCEPTED LIMITS ESTABLISHED BY THE VERIGENE I ASSAY TEMPERATURE TOLERANCE GUARD BAND RISK REPORT (03838).
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15170049 ↗MalfunctionJun 13, 2022Output Problem
A PM VISIT AT (B)(6) MEDICAL CENTER (B)(6) WAS SCHEDULED WITHIN WORK ORDER (B)(4). DURING THE SITE VISIT, THE HYBRIDIZATION (HYB) HEATER REQUIRED RECALIBRATION DUE TO FAILING INITIAL VERIFICATION AT SETPOINTS 1 AND 2. FIELD QUALITY UPDATED RISK ASSESSMENT QUESTION 2 TO 'YES' SINCE THE SETPOINT TEMPERATURES FAILED OUTSIDE THE ACCEPTED LIMITS ESTABLISHED BY THE VERIGENE I ASSAY TEMPERATURE TOLERANCE GUARD BAND RISK REPORT ((B)(4)).
Patient problems: Insufficient Information
MAUDE report 14682027 ↗MalfunctionJun 13, 2022Output Problem
THE SERVICE VISIT AT THE (B)(6) HOSPITAL WAS SCHEDULED PER CAPA-(B)(4) WITHIN WORK ORDER (B)(4). DURING THE SITE VISIT, THE HYBRIDIZATION (HYB) HEATER REQUIRED RECALIBRATION DUE TO FAILING INITIAL VERIFICATION AT SETPOINT 2. FIELD QUALITY UPDATED RISK ASSESSMENT QUESTION 2 TO 'YES' SINCE THE SETPOINT TEMPERATURE FAILED OUTSIDE THE ACCEPTED LIMITS ESTABLISHED BY THE VERIGENE I ASSAY TEMPERATURE TOLERANCE GUARD BAND RISK REPORT (03838).
Patient problems: Insufficient Information
MAUDE report 14681962 ↗MalfunctionJun 8, 2022Output Problem
THE SERVICE VISIT AT TALLAHASSEE MEMORIAL HOSPITAL WAS SCHEDULED PER (B)(4) WITHIN WORK ORDER WO-00200320. DURING THE SITE VISIT, THE HYBRIDIZATION (HYB) HEATER REQUIRED RECALIBRATION DUE TO FAILING INITIAL VERIFICATION AT SETPOINT 2. FIELD QUALITY UPDATED RISK ASSESSMENT QUESTION 2 TO 'YES' SINCE THE SETPOINT TEMPERATURE FAILED OUTSIDE THE ACCEPTED LIMITS ESTABLISHED BY THE VERIGENE I ASSAY TEMPERATURE TOLERANCE GUARD BAND RISK REPORT (03838).
Patient problems: Insufficient Information
MAUDE report 14637995 ↗
Other Instrumentation for clinical multiplex test systems devices
- Verigene® Processor SP 10-0000-07Luminex Corporation · Instrumentation for clinical multiplex test systems3 recalls15 reports
- BD MAX™ Vaginal Panel 443712Becton, Dickinson And Company · Instrumentation For Clinical Multiplex Test Systems1 recall50 reports
- DASH® Rapid PCR Instrument DASH-0002Nuclein, LLC · Instrumentation For Clinical Multiplex Test Systems2 recalls0 reports
- FilmArray® Torch Module HTFA-SUB-0103Biofire Diagnostics, LLC · Instrumentation For Clinical Multiplex Test Systems1 recall25 reports
- FilmArray® Torch System Base HTFA-ASY-0104Biofire Diagnostics, LLC · Instrumentation For Clinical Multiplex Test Systems1 recall4 reports
- FilmArray® 2.0 Instrument FLM2-ASY-0001Biofire Diagnostics, LLC · Instrumentation For Clinical Multiplex Test Systems1 recall3 reports
- FilmArray® 2.0 Instrument FLM2-ASY-0001-WBiofire Diagnostics, LLC · Instrumentation For Clinical Multiplex Test Systems1 recall0 reports
- FilmArray® Torch Module HTFA-ASY-0003-WBiofire Diagnostics, LLC · Instrumentation For Clinical Multiplex Test Systems1 recall0 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page